Effect of Nursing Intervention on Treatment Burden and Self-management Among Adolescents With Thalassemia
Effect of an Orem's Self-care Theory -Based Nursing Intervention on Treatment Burden and Self-management Among Adolescents With Thalassemia
This study aims to evaluate the effect of a nursing intervention based on Orem's self-care theory on treatment burden and self-management among adolescents diagnosed with thalassemia. Adolescents with thalassemia face significant physical and psychosocial challenges that affect their daily routines and treatment adherence. The intervention consists of educational and supportive sessions designed to enhance self-care agency and reduce treatment burden. Participants will be evaluated before and after the implementation of the nursing program to measure changes in treatment burden and self-management behaviors.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Abbas O Mijbas
- Telefonnummer: 07811038519 009647811038519
- E-mail: abbas.obaid2504m@conursing.uobaghdad.edu.iq
Studiesteder
-
-
Babylon
-
Hillah, Babylon, Irak, 51001
- Thalasemmia centers
-
Kontakt:
- Abbas O Mijbas
- Telefonnummer: 07811038519
- E-mail: abbas.obaid2504m@conursing.uobaghdad.edu.iq
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- adolescents aged 12-18 years.
- diagnosed with β-thalassemia major/transfusion-dependent β-thalassemia by a physician.
- Receiving regular blood transfusion therapy according to their treatment plan.
- Receiving regular iron chelation therapy.
- Able to communication and understanding sufficiently to complete in intervention.
- Willing to participate in the study with written informed assent from the adolescent and informed consent from the parent/ legal guardian.
Exclusion Criteria:
- adolescents with sever medical complication.
- adolescents with sever cognitive, intellectual, or developmental impairment that prevent understanding or participation in study.
- participants who have undergone or currently undergoing hematopoietic stem cell transplantation
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Ingen indgriben: Kontrolgruppe
|
|
|
Eksperimentel: Interventionsgruppe
|
A structured educational and supportive nursing program based on Orem's self-care theory, designed to enhance self-care agency, improve disease self-management, and reduce treatment burden among adolescents with thalassemia |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Self-management
Tidsramme: 8 weeks
|
Mean Score of Self-Management Measured by the Self-management and transition to adulthood with Rx (STARx). Self-management behaviors will be assessed using a validated Self-Management Questionnaire. The total score ranges from [0] to [90], where higher scores indicate better self-management practices. Baseline (pre-intervention) and 8 weeks post-intervention |
8 weeks
|
|
Treatment Burden
Tidsramme: 8 weeks
|
Treatment burden will be evaluated using the validated The Medication-Related Burden Quality of Life (MRB-QoL) . The total score ranges from [31] to [155], where higher scores indicate a greater perceived burden of treatment Baseline (pre-intervention) and 8 weeks post-intervention |
8 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Studiestol: Asmahan Q Mohammed, University of Baghdad
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- Mijbas-2026-1
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .